Gregory James Zahner, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peripheral Arterial Disease | 13 | 2020 | 1184 | 2.130 |
Why?
|
Intermittent Claudication | 3 | 2019 | 309 | 1.200 |
Why?
|
Medicare Part C | 2 | 2022 | 296 | 1.190 |
Why?
|
Radial Artery | 3 | 2018 | 194 | 1.110 |
Why?
|
Manometry | 3 | 2018 | 444 | 1.070 |
Why?
|
Veterans Health | 2 | 2018 | 216 | 0.700 |
Why?
|
Donor Selection | 1 | 2020 | 201 | 0.670 |
Why?
|
Blood Donors | 1 | 2020 | 355 | 0.650 |
Why?
|
Vasodilation | 2 | 2018 | 944 | 0.580 |
Why?
|
Ischemia | 2 | 2020 | 1911 | 0.480 |
Why?
|
Depression | 4 | 2020 | 7733 | 0.430 |
Why?
|
Leptin | 1 | 2019 | 1593 | 0.380 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1889 | 0.340 |
Why?
|
United States Department of Veterans Affairs | 3 | 2019 | 874 | 0.270 |
Why?
|
Fatty Acids, Omega-3 | 3 | 2019 | 1341 | 0.250 |
Why?
|
Inflammation | 2 | 2019 | 10578 | 0.200 |
Why?
|
Insurance Coverage | 2 | 2022 | 1895 | 0.190 |
Why?
|
United States | 9 | 2022 | 69693 | 0.180 |
Why?
|
Cost Control | 1 | 2022 | 624 | 0.170 |
Why?
|
Health Benefit Plans, Employee | 1 | 2022 | 332 | 0.170 |
Why?
|
Cross-Sectional Studies | 5 | 2019 | 24913 | 0.160 |
Why?
|
Resistin | 1 | 2018 | 170 | 0.160 |
Why?
|
Eicosapentaenoic Acid | 2 | 2019 | 582 | 0.150 |
Why?
|
Risk Assessment | 7 | 2020 | 23320 | 0.150 |
Why?
|
Erythrocyte Membrane | 1 | 2019 | 442 | 0.150 |
Why?
|
Limb Salvage | 1 | 2019 | 433 | 0.150 |
Why?
|
Ankle Brachial Index | 1 | 2017 | 154 | 0.140 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2019 | 392 | 0.140 |
Why?
|
Education, Professional | 1 | 2017 | 54 | 0.140 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2019 | 546 | 0.130 |
Why?
|
Heart Diseases | 2 | 2018 | 2789 | 0.130 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2018 | 1155 | 0.120 |
Why?
|
HIV Infections | 1 | 2020 | 16678 | 0.120 |
Why?
|
Aged | 13 | 2020 | 162944 | 0.120 |
Why?
|
Multivariate Analysis | 2 | 2018 | 12242 | 0.120 |
Why?
|
Fish Oils | 1 | 2017 | 469 | 0.120 |
Why?
|
Adiponectin | 1 | 2019 | 1099 | 0.110 |
Why?
|
Docosahexaenoic Acids | 1 | 2019 | 875 | 0.110 |
Why?
|
Problem-Based Learning | 1 | 2016 | 359 | 0.100 |
Why?
|
Middle Aged | 12 | 2020 | 213127 | 0.100 |
Why?
|
Vascular Surgical Procedures | 1 | 2020 | 1473 | 0.100 |
Why?
|
Affect | 1 | 2019 | 1473 | 0.100 |
Why?
|
Male | 16 | 2020 | 349538 | 0.100 |
Why?
|
Risk Factors | 7 | 2020 | 72145 | 0.100 |
Why?
|
Inpatients | 2 | 2020 | 2495 | 0.100 |
Why?
|
Comorbidity | 3 | 2020 | 10372 | 0.100 |
Why?
|
Critical Illness | 2 | 2020 | 2665 | 0.090 |
Why?
|
Clinical Clerkship | 1 | 2016 | 531 | 0.090 |
Why?
|
Female | 15 | 2020 | 379592 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2018 | 3199 | 0.080 |
Why?
|
Dietary Supplements | 2 | 2019 | 3294 | 0.080 |
Why?
|
Linear Models | 1 | 2018 | 5948 | 0.080 |
Why?
|
Patient Discharge | 1 | 2020 | 3300 | 0.080 |
Why?
|
Databases, Factual | 2 | 2020 | 7716 | 0.080 |
Why?
|
Endovascular Procedures | 1 | 2020 | 1973 | 0.070 |
Why?
|
Education, Medical, Undergraduate | 1 | 2016 | 1004 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2018 | 4414 | 0.070 |
Why?
|
C-Reactive Protein | 1 | 2018 | 3766 | 0.070 |
Why?
|
Endothelium, Vascular | 1 | 2018 | 4455 | 0.070 |
Why?
|
Heart Rate | 1 | 2017 | 4091 | 0.070 |
Why?
|
Humans | 17 | 2021 | 742088 | 0.070 |
Why?
|
Mental Health | 1 | 2019 | 2997 | 0.070 |
Why?
|
Veterans | 1 | 2019 | 2513 | 0.060 |
Why?
|
Odds Ratio | 1 | 2017 | 9846 | 0.060 |
Why?
|
Cardiology | 1 | 2016 | 1658 | 0.060 |
Why?
|
Time Factors | 3 | 2020 | 40054 | 0.060 |
Why?
|
Prognosis | 3 | 2018 | 29010 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2020 | 57683 | 0.050 |
Why?
|
Logistic Models | 1 | 2017 | 13403 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15056 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2020 | 62966 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2020 | 77098 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15530 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2017 | 21719 | 0.040 |
Why?
|
Chromatography, Gas | 1 | 2019 | 156 | 0.040 |
Why?
|
Stroke | 2 | 2018 | 9963 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2020 | 15244 | 0.040 |
Why?
|
Arachidonic Acid | 1 | 2019 | 434 | 0.040 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2019 | 227 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2018 | 11690 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6534 | 0.040 |
Why?
|
Hospitals, Veterans | 1 | 2018 | 404 | 0.030 |
Why?
|
Placebos | 1 | 2019 | 1677 | 0.030 |
Why?
|
Myocardial Revascularization | 1 | 2018 | 841 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12344 | 0.030 |
Why?
|
Frail Elderly | 1 | 2018 | 691 | 0.030 |
Why?
|
Curriculum | 2 | 2017 | 3589 | 0.030 |
Why?
|
California | 1 | 2017 | 1400 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 21596 | 0.030 |
Why?
|
Administration, Oral | 1 | 2019 | 3913 | 0.020 |
Why?
|
Mentors | 1 | 2016 | 630 | 0.020 |
Why?
|
Geriatric Assessment | 1 | 2018 | 1369 | 0.020 |
Why?
|
Program Development | 1 | 2016 | 1314 | 0.020 |
Why?
|
Up-Regulation | 1 | 2018 | 4211 | 0.020 |
Why?
|
Health Expenditures | 1 | 2021 | 2346 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2016 | 2536 | 0.020 |
Why?
|
Program Evaluation | 1 | 2016 | 2485 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10392 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2018 | 2838 | 0.020 |
Why?
|
Chronic Disease | 1 | 2020 | 9144 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2019 | 12017 | 0.020 |
Why?
|
Quality Improvement | 1 | 2016 | 3738 | 0.010 |
Why?
|
Quality of Life | 1 | 2021 | 12730 | 0.010 |
Why?
|
Incidence | 1 | 2018 | 20928 | 0.010 |
Why?
|
Cohort Studies | 1 | 2018 | 40450 | 0.010 |
Why?
|